Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure

International Journal of Cardiology
Urban Alehagen, Ulf Dahlström

Abstract

Heart failure has a serious prognosis. However, among elderly patients the panorama of concomitant diseases makes it difficult to implement the results from epidemiological studies. The aim of this study was to evaluate the influence of different clinical variables on cardiovascular mortality during a long-term follow-up. In all, 474 elderly patients (age 65-82 years) in primary health care were evaluated and followed during a 10 year period. All patients had symptoms associated with heart failure and were examined by a cardiologist. Blood samples including NT-proBNP were analyzed, and ECG and Doppler echocardiography were assessed. Both the systolic and diastolic function was evaluated. Functional capacity was evaluated according to the NYHA classification. During the 10 years of follow-up those with the highest quartile of plasma concentration of NT-proBNP had almost four times increased risk of cardiovascular mortality. Impaired systolic function, diabetes and reduced functional capacity were all markers of increased risk of cardiovascular mortality. All variables were also evaluated after 5 years, with higher risk ratios for a majority of variables. In this study 474 patients with symptoms of heart failure were followed dur...Continue Reading

References

Jul 1, 1974·The American Journal of Cardiology·W B KannelW P Castelli
Jul 2, 1999·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·J KarlJ Schenk
Jun 1, 2002·Journal of the American College of Cardiology·Gillian A WhalleyNorman Sharpe
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Aug 13, 2003·Circulation·Thomas J WangRamachandran S Vasan
Feb 28, 2004·European Journal of Heart Failure·Marcello GalvaniFilippo Ottani
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Véronique L RogerSteven J Jacobsen
Oct 8, 2004·Journal of Cardiac Failure·Eyal ShaharRussell V Luepker
Oct 13, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Markus RothenburgerHans Heinrich Scheld
Feb 18, 2005·The New England Journal of Medicine·Charlotte KragelundRolf Steffensen
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·S SejilV Lassmann-Vague
Nov 30, 2006·Current Heart Failure Reports·Jerry D Estep, David Aguilar
Dec 13, 2006·International Journal of Cardiology·A DirkaliV A W M Umans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.